ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

TGTX TG Therapeutics Inc

16,45
-0,31 (-1,85%)
15 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
TG Therapeutics Inc TGTX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,31 -1,85% 16,45 01:00:02
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
16,64 16,235 16,97 16,55 16,76
mais cotações »

Notícias Recentes

Data Hora Fonte Título
07/06/202408:50GLOBETG Therapeutics to Participate in the Goldman Sachs 45th..
03/06/202408:30GLOBETG Therapeutics to Participate in the Jefferies Global..
31/05/202408:30GLOBETG Therapeutics Announces Presentations for BRIUMVI®..
28/05/202408:30GLOBETG Therapeutics Announces Schedule of Upcoming Presentations..
01/05/202408:00GLOBETG Therapeutics Provides Business Update and Reports First..
30/04/202417:55GLOBETG Therapeutics to Host Conference Call on First Quarter..
18/04/202408:30GLOBETG Therapeutics Announces Additional Data Presentations for..
18/04/202408:00GLOBETG Therapeutics Awarded National Contract by the Department..
15/04/202408:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
08/03/202409:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
01/03/202409:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
28/02/202409:00GLOBETG Therapeutics Provides Business Update and Reports Fourth..
27/02/202409:30GLOBETG Therapeutics Announces Issuance of Additional Patents for..
26/02/202409:00GLOBETG Therapeutics Announces European Launch of BRIUMVI®..
23/02/202409:30GLOBETG Therapeutics to Host Conference Call on Fourth Quarter..
20/02/202409:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
10/01/202409:00GLOBETG Therapeutics Provides Preliminary Fourth Quarter and Full..
09/01/202411:20APSBiotech Massively Bid Up Before Opening Bell
09/01/202409:00GLOBETG Therapeutics Announces Global License Agreement with..
05/01/202409:30GLOBETG Therapeutics to Participate in the 42nd Annual J.P...
27/11/202309:30GLOBETG Therapeutics to Participate in the 6th Annual Evercore..
03/11/202308:30GLOBETG Therapeutics to Participate in the 5th Annual Guggenheim..
01/11/202308:30GLOBETG Therapeutics Provides Business Update and Reports Third..
30/10/202308:30GLOBETG Therapeutics to Host Conference Call on Third Quarter..
12/10/202312:00GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
11/10/202311:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
02/10/202308:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
22/09/202308:30GLOBETG Therapeutics to Participate in the 2023 Cantor Global..
07/09/202308:30GLOBETG Therapeutics to Participate in the H.C. Wainwright 25th..
01/08/202308:15GLOBETG Therapeutics Provides Business Update and Reports Second..
01/08/202308:00GLOBETG Therapeutics and Neuraxpharm Announce Ex-US..
31/07/202309:30GLOBETG Therapeutics to Host Conference Call on Second Quarter..

Seu Histórico Recente

Delayed Upgrade Clock